Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
39 hedge funds and large institutions have $187M invested in Alimera Sciences in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 6 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
11% more funds holding
Funds holding: 35 → 39 (+4)
12% less capital invested
Capital invested by funds: $212M → $187M (-$25.5M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.51M |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$893K |
| 3 |
State Street
Boston,
Massachusetts
|
+$506K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$453K |
| 5 |
Millennium Management
New York
|
+$357K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.07M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$2.69M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$2.4M |
| 4 |
ACM
Altium Capital Management
New York
|
-$419K |
| 5 |
CC
Clearline Capital
New York
|
-$319K |
ALIM Hedge Fund Activity: Q1 2024 in Review
39 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2024, worth a combined $187M — down 12% from $212M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ALIM positions and 6 closed out — a net gain of 4 holders — while 16 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.51M. The largest seller was Morgan Stanley, cutting an estimated $5.07M.
- 39 institutional investors held Alimera Sciences (ALIM) as of Q1 2024, up from 35 in Q4 2023.
- Funds reported $187M of Alimera Sciences stock for Q1 2024, down 12% quarter-over-quarter.
- 10 funds opened new Alimera Sciences positions in Q1 2024 and 6 closed out, a net change of +4 holders.
- The largest Alimera Sciences buyer in Q1 2024 was Vanguard Group, an estimated $1.51M added.
- The largest Alimera Sciences seller in Q1 2024 was Morgan Stanley, an estimated $5.07M sold.
Based on aggregated 13F filings for Q1 2024.